Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$10.27 - $13.29 $17,797 - $23,031
-1,733 Reduced 3.67%
45,486 $483,000
Q3 2022

Nov 08, 2022

SELL
$9.93 - $17.44 $90,273 - $158,547
-9,091 Reduced 16.14%
47,219 $492,000
Q2 2022

Aug 12, 2022

SELL
$7.45 - $12.83 $20,562 - $35,410
-2,760 Reduced 4.67%
56,310 $709,000
Q1 2022

May 13, 2022

BUY
$9.75 - $14.44 $82,875 - $122,740
8,500 Added 16.81%
59,070 $640,000
Q4 2021

Feb 11, 2022

BUY
$13.17 - $20.94 $666,006 - $1.06 Million
50,570 New
50,570 $711,000
Q2 2020

Aug 14, 2020

SELL
$2.94 - $9.1 $275,092 - $851,477
-93,569 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$2.27 - $6.2 $3,411 - $9,318
-1,503 Reduced 1.58%
93,569 $330,000
Q4 2019

Feb 13, 2020

BUY
$3.46 - $6.93 $328,949 - $658,848
95,072 New
95,072 $544,000
Q2 2018

Aug 13, 2018

SELL
$15.15 - $20.75 $317,468 - $434,816
-20,955 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$14.65 - $19.9 $292,809 - $397,741
-19,987 Reduced 48.82%
20,955 $416,000
Q4 2017

Feb 13, 2018

SELL
$17.3 - $24.08 $10,553 - $14,688
-610 Reduced 1.47%
40,942 $766,000
Q3 2017

Nov 13, 2017

SELL
$15.2 - $21.5 $648,508 - $917,297
-42,665 Reduced 50.66%
41,552 $893,000
Q2 2017

Aug 14, 2017

BUY
N/A
12,569 Added 17.54%
84,217 $813,000
Q1 2017

Apr 17, 2019

SELL
N/A
-385 Reduced 0.53%
71,648 $426,000
Q4 2016

Apr 17, 2019

SELL
N/A
-9,434 Reduced 11.58%
72,033 $285,000
Q3 2016

Apr 17, 2019

BUY
N/A
81,467
81,467 $855,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.44B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.